drugset / Trial / NCT07012512

Adjusted Study Protocol: Within-Subject Paired-Eye Design Comparing Pilocarpine 0.1%, Phentolamine 0.75%, and Combination Therapy for Cyclopentolate Reversal in Children

NCT07012512

Not yet recruiting 60 enrolled Mansoura University
RandomizedParallel-groupDouble-blindOther

Summary

The study aims at reversing pupillary dilatation. and cycloplegia in children undergoing cycloplegic refraction for eyeglasses prescription and ocular examination. This will be achieved using pilocarpine , phentolamine or a combination. This may help decrease the glare and improve near vision early to decrease unwanted effects of cycloplegic drops.

Timeline

Start
2025-06-01
Primary completion
2025-12-01
Completion
2025-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Phentolamine Small molecule 0.75 % Other
Subject Pilocarpine Unknown 0.1 % Other